Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.
3.

Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.

Akkoyunlu M, Malawista SE, Anguita J, Fikrig E.

Infect Immun. 2001 Sep;69(9):5577-88.

5.

Human granulocytic ehrlichiosis.

Bakken JS, Dumler JS.

Clin Infect Dis. 2000 Aug;31(2):554-60. Epub 2000 Sep 14. Review.

PMID:
10987720
6.
7.

Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection.

Moore TA, Newstead MW, Strieter RM, Mehrad B, Beaman BL, Standiford TJ.

J Immunol. 2000 Jan 15;164(2):908-15.

8.
10.
11.

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration.

White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM.

J Biol Chem. 1998 Apr 24;273(17):10095-8.

12.

Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils.

Morrison TB, Weis JH, Weis JJ.

J Immunol. 1997 May 15;158(10):4838-45.

PMID:
9144499
13.

Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.

Quan JM, Martin TR, Rosenberg GB, Foster DC, Whitmore T, Goodman RB.

Biochem Biophys Res Commun. 1996 Feb 15;219(2):405-11.

PMID:
8605000
14.

Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS.

JAMA. 1996 Jan 17;275(3):199-205.

PMID:
8604172
15.

Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH.

JAMA. 1994 Jul 20;272(3):212-8.

PMID:
8022040

Supplemental Content

Support Center